As the COVID-19 pandemic reshaped the global economy, some pharma companies coped better than others. The who and why offer some hints about who's best suited t...

Novartis and iHeartRadio hit a high note with award-winning feel-good singer Andy Grammer for a virtual concert to raise multiple sclerosis awareness. The event exte...

The drug re-packaging business provides a convenient way for doctors and pharmacies to dispense tailor-made doses to patients—but when a drug turns up in a mismarked...

With COVID-19 top of mind for many contract developers and manufacturers right now, Thermo Fisher Scientific has blueprinted a manufacturing boost to&...

When W2O CEO Jim Weiss started the agency, he likely didn’t imagine the flurry of acquisitions, hundreds of new hires that are shaping the pharma and healthcare...

One year ago this week, the COVID-19 pandemic hit home with Americans when Tom Hanks revealed he had tested positive and the NBA postponed its season ...

After enduring a turbulent few years, point-of-care advertising and marketing company Outcome Health is getting a makeover, thanks to a merger. PatientPoint is mer...

GlaxoSmithKline managed to notch some wins during the pandemic-challenged year of 2020, but COVID-19 took its toll—not only on the British pharma's finance...

Eli Lilly is counting on its new meds—including rheumatoid arthritis drug Olumiant—to drive growth in the years to come. With a new trial win in the autoim...

Heading into last year, Novavax had just $80 million in cash and a “financial operating horizon” of six months, its CEO said this week. That's all changed. Nowadays,...